Partnering Opportunities

Text size
view with small font size
view with medium font size
view with large font size

Since Kyowa Kirin Pharmaceutical Research's (KKR) founding in 1988, KKR has acted as Kyowa Kirin Co., Ltd.'s agent to facilitate the company's open innovation activities in North America.


KKR actively seeks early stage discovery and translational research collaborations with academia and industry. We focus on novel technologies and targeting opportunities in immunology and immune-related diseases and welcome the opportunity to explore collaborative opportunities in this area.


KKR actively seeks external opportunities from discovery through pre-clinical stages, to enrich its research pipeline in the area of immunology (inflammatory and autoimmune diseases).

To Page Top